{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,1,27]],"date-time":"2026-01-27T23:28:43Z","timestamp":1769556523774,"version":"3.49.0"},"reference-count":29,"publisher":"Frontiers Media SA","content-domain":{"domain":["frontiersin.org"],"crossmark-restriction":true},"short-container-title":["Front. Oncol."],"DOI":"10.3389\/fonc.2016.00208","type":"journal-article","created":{"date-parts":[[2016,10,10]],"date-time":"2016-10-10T08:41:55Z","timestamp":1476088915000},"update-policy":"https:\/\/doi.org\/10.3389\/crossmark-policy","source":"Crossref","is-referenced-by-count":15,"title":["Skeletal Metastasis as Detected by 18F-FDG PET with Negative CT of the PET\/CT: Frequency and Impact on Cancer Staging and\/or Management"],"prefix":"10.3389","volume":"6","author":[{"given":"Fatma","family":"Ahmed","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Razi","family":"Muzaffar","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Hermina","family":"Fernandes","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Yifan","family":"Tu","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Batool","family":"Albalooshi","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Medhat M.","family":"Osman","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"1965","published-online":{"date-parts":[[2016,10,10]]},"reference":[{"issue":"1","key":"B1","doi-asserted-by":"publisher","first-page":"162","DOI":"10.1016\/j.juro.2010.03.034","article-title":"Skeletal related events, bone metastasis and survival of prostate cancer","volume":"184","author":"Norgaard","year":"2010","journal-title":"J Urol"},{"issue":"2","key":"B2","doi-asserted-by":"publisher","first-page":"177","DOI":"10.1038\/pcan.2011.7","article-title":"Mortality following bone metastasis and skeletal-related events among men with prostate cancer","volume":"14","author":"Sathiakumar","year":"2011","journal-title":"Prostate Cancer Prostatic Dis"},{"issue":"5","key":"B3","first-page":"317","article-title":"The cost of treating skeletal-related events in patients with prostate cancer","volume":"14","author":"Lage","year":"2008","journal-title":"Am J Manag Care"},{"issue":"4","key":"B4","doi-asserted-by":"publisher","first-page":"579","DOI":"10.1093\/annonc\/mdi122","article-title":"The significance of skeletal-related events for the health-related quality of life of patients with metastatic prostate cancer","volume":"16","author":"Weinfurt","year":"2005","journal-title":"Ann Oncol"},{"key":"B5","doi-asserted-by":"publisher","first-page":"3440","DOI":"10.1200\/JCO.2007.11.2854","article-title":"Fusion of metabolic function and morphology:sequential [18F]fluorodeoxyglucose positron-emission tomography\/computed tomography studies yield new insights into the natural history of bone metastases in breast cancer","volume":"25","author":"Du","year":"2007","journal-title":"J Clin Oncol"},{"key":"B6","doi-asserted-by":"publisher","first-page":"922","DOI":"10.1016\/j.clinimag.2013.03.004","article-title":"The clinical value of 18F-FDG PET\/CT in the evaluation of bone metastases undetermined origin","volume":"37","author":"Hu","year":"2013","journal-title":"Clin Imaging"},{"key":"B7","doi-asserted-by":"publisher","first-page":"223","DOI":"10.1097\/01.blo.0000059580.08469.3e","article-title":"Treatment of osseous metastases in patients with renal cell carcinoma","volume":"409","author":"Jung","year":"2003","journal-title":"Clin Orthop Relat Res"},{"issue":"8","key":"B8","doi-asserted-by":"publisher","first-page":"1794","DOI":"10.2106\/JBJS.F.00603","article-title":"Patient survival after surgery for osseous metastases from renal cell carcinoma","volume":"89","author":"Lin","year":"2007","journal-title":"J Bone Joint Surg Am"},{"issue":"4","key":"B9","doi-asserted-by":"publisher","first-page":"299","DOI":"10.1080\/00365590410028818","article-title":"Presumed radically treated renal cell carcinoma \u2013 recurrence of the disease and prognostic factors for subsequent survival","volume":"38","author":"Beisland","year":"2004","journal-title":"Scand J Urol Nephrol"},{"issue":"1","key":"B10","doi-asserted-by":"publisher","first-page":"58","DOI":"10.1055\/s-2006-921465","article-title":"Surgical treatment and evaluation of prognostic factors in spinal metastases of renal cell carcinoma","volume":"144","author":"Ulmar","year":"2006","journal-title":"Z Orthop Ihre Grenzgeb"},{"key":"B11","doi-asserted-by":"publisher","first-page":"265","DOI":"10.1002\/(SICI)1096-9098(199812)69:4265::AID-JSO123.0.CO;2-7","article-title":"Detection of occult metastases in lung carcinomas: progress and implications for lung cancer staging","volume":"69","author":"Cote","year":"1998","journal-title":"J Surg Oncol"},{"key":"B12","doi-asserted-by":"publisher","first-page":"2252","DOI":"10.1002\/(SICI)1097-0142(20000515)88:102252::AID-CNCR83.0.CO;2-Q","article-title":"Prognostic significance of an increased number of micrometastatic tumor cells in the bone marrow of patients with first recurrence of breast carcinoma","volume":"88","author":"Janni","year":"2000","journal-title":"Cancer"},{"key":"B13","doi-asserted-by":"publisher","first-page":"1297","DOI":"10.1002\/1097-0142(19930215)71:41297::AID-CNCR28207104213.0.CO;2-S","article-title":"Prognostic significance of bone metastases in patients with metastatic prostate cancer","volume":"71","author":"Yamashita","year":"1993","journal-title":"Cancer"},{"key":"B14","doi-asserted-by":"publisher","first-page":"86","DOI":"10.1016\/j.suronc.2013.01.002","article-title":"Comparison of 18FDG PET-CT and bone scintigraphy for detection of bone metastases in breast cancer patients. A meta-analysis","volume":"22","author":"Rong","year":"2013","journal-title":"Surg Oncol"},{"key":"B15","doi-asserted-by":"publisher","first-page":"7","DOI":"10.1186\/s12880-015-0047-2","article-title":"A comparative study of 18F-fluorodeoxyglucose positron emission tomography\/computed tomography and 99mTc-MDP whole-body bone scanning for imaging osteolytic bone metastases","volume":"15","author":"Lin","year":"2015","journal-title":"BMC Med Imaging"},{"key":"B16","first-page":"1369","article-title":"A combined PET\/CT scanner for clinical oncology","volume":"41","author":"Beyer","year":"2000","journal-title":"J Nucl Med"},{"key":"B17","doi-asserted-by":"publisher","first-page":"223","DOI":"10.1016\/S1095-0397(01)00055-3","article-title":"Combined PET\/CT imaging in oncology: impact on patient management","volume":"3","author":"Kluetz","year":"2000","journal-title":"Clin Positron Imaging"},{"key":"B18","doi-asserted-by":"publisher","first-page":"98","DOI":"10.1007\/s11307-010-0327-8","article-title":"The use of F-18 choline PET in the assessment of bone metastases in prostate cancer: correlation with morphological changes on CT","volume":"12","author":"Beheshti","year":"2010","journal-title":"Mol Imaging Biol"},{"issue":"3","key":"B19","doi-asserted-by":"publisher","first-page":"349","DOI":"10.1016\/j.acra.2011.10.018","article-title":"Meta-analysis comparison of F-18 fl uorodeoxyglucose-positron emission tomography and bone scintigraphy in the detection of bone metastasis in patients with lung cancer","volume":"19","author":"Chang","year":"2012","journal-title":"Acad Radiol"},{"key":"B20","doi-asserted-by":"publisher","first-page":"1253","DOI":"10.1007\/s00259-005-1842-8","article-title":"Pitfalls of FDG-PET for the diagnosis of osteoblastic bone metastases in patients with breast cancer","volume":"32","author":"Nakai","year":"2005","journal-title":"Eur J Nucl Med Mol Imaging"},{"issue":"2","key":"B21","doi-asserted-by":"publisher","first-page":"96","DOI":"10.4184\/asj.2013.7.2.96","article-title":"18F-FDG PET\/CT for diagnosis of osteosclerotic and osteolytic vertebral metastatic lesions: comparison with bone scintigraphy","volume":"7","author":"Uchida","year":"2013","journal-title":"Asian Spine J"},{"issue":"Suppl 3","key":"B22","doi-asserted-by":"crossref","first-page":"S1","DOI":"10.6004\/jnccn.2009.0076","article-title":"NCCN task force report: bone health in cancer care","volume":"7","author":"Gralow","year":"2009","journal-title":"J Natl Compr Canc Netw"},{"key":"B23","doi-asserted-by":"publisher","first-page":"584","DOI":"10.1038\/nrc867","article-title":"Metastasis to bone: causes, consequences and therapeutic opportunities","volume":"8","author":"Mundy","year":"2002","journal-title":"Nat Rev Cancer"},{"key":"B24","doi-asserted-by":"publisher","first-page":"24","DOI":"10.1016\/j.clbc.2012.09.004","article-title":"A prospective study of bone tumor response assessment in metastatic breast cancer","volume":"13","author":"Hayashi","year":"2013","journal-title":"Clin Breast Cancer"},{"issue":"3","key":"B25","doi-asserted-by":"publisher","first-page":"279","DOI":"10.1111\/tbj.12264","article-title":"Prognostic evaluation of breast cancer patients with evident bone marrow metastasis","volume":"20","author":"Demir","year":"2014","journal-title":"Breast J"},{"key":"B26","doi-asserted-by":"publisher","first-page":"102","DOI":"10.4103\/1450-1147.172301","article-title":"18 F sodium fluoride PET\/CT in patients with prostate cancer: quantification of normal tissues, benign degenerative lesions, and malignant lesions","volume":"15","author":"Oldan","year":"2016","journal-title":"World J Nucl Med"},{"key":"B27","doi-asserted-by":"publisher","first-page":"50","DOI":"10.1053\/snuc.2001.18746","article-title":"The role of positron emission tomography in skeletal disease","volume":"31","author":"Cook","year":"2001","journal-title":"Semin Nucl Med"},{"key":"B28","doi-asserted-by":"publisher","first-page":"252","DOI":"10.1007\/s11307-011-0486-2","article-title":"Prospective evaluation of (99m) Tc MDP scintigraphy, (18) F NaF PET\/CT, and (18) F FDG PET\/CT for detection of skeletal metastases","volume":"14","author":"Iagaru","year":"2012","journal-title":"Mol Imaging Biol"},{"key":"B29","first-page":"272","article-title":"Assessment of malignant skeletal disease: initial experience with 18F-fluoride PET\/CT and comparison between 18F-fluoride PET and 18F-fluoride PET\/CT","volume":"45","author":"Even-Sapir","year":"2004","journal-title":"J Nucl Med"}],"container-title":["Frontiers in Oncology"],"original-title":[],"link":[{"URL":"http:\/\/journal.frontiersin.org\/article\/10.3389\/fonc.2016.00208\/full","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2017,6,25]],"date-time":"2017-06-25T00:44:26Z","timestamp":1498351466000},"score":1,"resource":{"primary":{"URL":"http:\/\/journal.frontiersin.org\/article\/10.3389\/fonc.2016.00208\/full"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2016,10,10]]},"references-count":29,"URL":"https:\/\/doi.org\/10.3389\/fonc.2016.00208","relation":{},"ISSN":["2234-943X"],"issn-type":[{"value":"2234-943X","type":"electronic"}],"subject":[],"published":{"date-parts":[[2016,10,10]]}}}